Universal-Beteiligungs- und Servicegesellschaft’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.64M Sell
109,284
-11,037
-9% -$165K ﹤0.01% 1282
2025
Q1
$1.94M Sell
120,321
-1,832
-1% -$29.6K ﹤0.01% 1183
2024
Q4
$2.84M Buy
+122,153
New +$2.84M 0.01% 829